Abbott Laboratories outperforms its competitors

Post Views: 155 Abbott Laboratories discovers, develops, manufactures and sells healthcare products worldwide. The company operates in four segments: Established pharmaceuticals, diagnostic products, food products and medical devices. Abbott Laboratories (NYSE: ABT) declared a $ 0.45 / share quarterly dividend, according to the previous one. The company serves customers in more than 160 countries. It is good to wait for the correction to come out. Breaking and testing the upper (red) border of the flag is a more conservative but less risky entry. Bank analysts are mainly buy positions. The average price they forecast is $ 123.47 at the current price of $ 117.21, which is only a 5.3% return. EPS and Revenue are positive with a tendency to rise…